INS and Insulin resistance: Studies have shown that it is more stable, easily available, and cost-effective than other alternative markers, such as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and the quantitative insulin check index (QUICKI) (Wang et al., 2021).